COL4A3突变通过NOX4/MMP-2通路诱导足细胞凋亡
本研究探讨COL4A3突变致足细胞凋亡的机制,纳入常染色体显性Alport综合征(ADAS)患者,以微小病变(MCD)为对照,进行肾小球微阵列分析,并构建突变足细胞(p.C1616Y)及129小鼠(p.C1615Y)模型。结果显示NOX4/H2O2、MMP-2及足细胞凋亡相关基因显著上调;抑制NOX4可减少足细胞凋亡、下调MMP-2并减轻蛋白尿和肾脏病理,抑制MMP-2仅减少凋亡而不影响NOX4表达,提示NOX4可能通过调控MMP-2诱导足细胞凋亡。
要点
- ADAS患者肾小球中NOX4/H2O2、MMP-2及足细胞凋亡相关基因显著上调。
- 抑制NOX4可减少足细胞凋亡、下调MMP-2,并减轻蛋白尿和肾脏病理。
- 抑制MMP-2减少足细胞凋亡,但NOX4表达不变,提示NOX4可能通过MMP-2起作用。
核心结论
- NOX4可能通过调控MMP-2诱导COL4A3突变患者的足细胞凋亡。
研究设计与样本
- 纳入ADAS患者,以MCD患者为对照,对分离的肾小球进行微阵列分析并验证。
- 构建对应突变的人足细胞(p.C1616Y)和129小鼠(p.C1615Y,为人p.C1616Y的小鼠同源突变)。
- 在转基因小鼠和足细胞中验证差异表达基因,并给予MMP-2抑制剂(SB-3CT)和NOX4抑制剂(GKT137831)。
- 通过实时PCR、免疫组化和western blot在ADAS患者肾组织中验证NOX4/MMP-2/凋亡通路。
主要发现
- 微阵列分析显示NOX4/H2O2、MMP-2和足细胞凋亡相关基因显著上调。
- 上述基因在突变人足细胞(p.C1616Y)和/或小鼠模型(p.C1615Y)中经实时PCR、组织学分析和western blot验证。
- 抑制NOX4在体内和体外均使足细胞凋亡被消除、MMP-2表达下调;体内抑制NOX4还减轻尿白蛋白-肌酐比值、24小时蛋白尿和肾脏病理病变。
- 抑制MMP-2在体内和体外均减轻足细胞凋亡,而NOX4表达保持不变。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Podocyte apoptosis is a common mechanism driving progression in Alport syndrome (AS). This study aimed to investigate the mechanism of podocyte apoptosis caused by COL4A3 mutations. METHODS: We recruited patients with autosomal dominant AS (ADAS). Patients with minimal change disease (MCD) were recruited as controls. Microarray analysis was carried out on isolated glomeruli from the patients and validated. Then, corresponding mutant human podocytes (p.C1616Y) and 129 mice (p.C1615Y, the murine homolog to the human p.C1616Y) were constructed. The highest differentially expressed genes (DEGs) from microarray analysis were validated in transgenic mice and podocytes before and after administration of MMP-2 inhibitor (SB-3CT) and NOX4 inhibitor (GKT137831). We further validated NOX4/MMP-2/apoptosis pathway by real-time polymerase chain reaction (PCR), immunohistochemistry, and western blot in renal tissues from the ADAS patients. RESULTS: Using microarray analysis, we observed that DEGs, including NOX4/H2O2, MMP-2, and podocyte apoptosis-related genes were significantly upregulated. These genes were validated by real-time PCR, histologic analysis, and western blot in corresponding mutant human podocyte (p.C1616Y) and/or mice models (p.C1615Y). Moreover, we found podocyte apoptosis was abrogated and MMP-2 expression was down-regulated both in vivo and in vitro by NOX4 inhibition, urinary albumin-to-creatinine ratio, 24-hour proteinuria; and renal pathologic lesion was attenuated by NOX4 inhibition in vivo. Furthermore, podocyte apoptosis was attenuated whereas NOX4 expression remained the same by inhibition of MMP-2 both in vivo and in vitro. CONCLUSION: These results indicated that NOX4 might induce podocyte apoptosis through the regulation of MMP-2 in patients with COL4A3 mutations. Our findings provided new insights into the mechanism of ADAS.
引用
- Tong J, Zheng Q, Gu X, et al. COL4A3 Mutation Induced Podocyte Apoptosis by Dysregulation of NADPH Oxidase 4 and MMP-2. Kidney Int Rep. 2023. PMID: 37705901. doi:10.1016/j.ekir.2023.06.007
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。